Hyphens Pharma International Limited (\u201c\u51ef\u5e06\u836f\u5242\u56fd\u9645\u6709\u9650\u516c\u53f8\u201d, \u201cHyphens Pharma\u201d, or the \u201cCompany\u201d, and together with its subsidiaries, the \u201cGroup\u201d), Singapore\u2019s leading specialty pharmaceutical and consumer healthcare group, is pleased to announce that its subsidiary, Ocean Health Pte Ltd (\u201cOcean Health\u201d), has signed a Distribution Agreement (\u201cDA\u201d) with SUTL Corporation (Hong Kong) Ltd (\u201cSUTL HK\u201d) to appoint SUTL HK as an exclusive distributor of Ocean Health\u00ae supplements. Under the DA, SUTL HK will be granted exclusive rights to distribute Ocean Health\u00ae supplement products in the Hong Kong Special Administrative Region (\u201cHK SAR\u201d), Macau and Duty-Free Channels in China.<\/p>\n
Ocean Health is a leading home-grown health supplements company in Singapore, offering a wide range of high-quality products at affordable prices, and is best known for its no. 1 Omega-3 fish oil, Multivitamins and Joint-RX. Mr Lim See Wah, Chairman, Executive Director & Chief Executive Officer of Hyphens Pharma commented: \u201cWe are honoured to partner SUTL HK, a well-known and established corporation, to distribute Ocean Health\u00ae products. Through this partnership, we look forward to broadening and establishing a stronger brand awareness of Ocean Health\u00ae in Asia.\u201d In HK SAR, the sales of vitamins and dietary supplements has also grown 2.7 per cent to US$722 Mr Arthur Tay, Chairman and Chief Executive Officer of SUTL Global Pte Ltd also commented: \u201cWe are indeed excited about the partnership with Ocean Health for the exclusive distribution rights of healthcare products in HK SAR, Macau and Duty-Free Channels in China. This is especially timely and critical when we\u2019re in the midst of a global pandemic where health safety is of primary concern and importance.\u201d<\/p>\n There will not be a material effect on the net tangible assets or earnings per share of the Group for the financial year ending 31 December 2020.<\/p>\n
\nmillion last year, despite a\u00a0drop of 11 per cent in overall retail sales<\/a>.<\/p>\n